Taurin-SOLOFARM (Taurin-SOLOFARM)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceTaurineTaurine
Similar drugsTo uncover
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Igrele®
    drops d / eye 
    KVADRAT-S, LLC     Russia
  • CardioActiv® Taurine
    pills inwards 
    EVALAR, CJSC     Russia
  • Taurine
    drops d / eye 
    Pharmaceutical firm LEKKO, ZAO     Russia
  • Taurine
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Taurine
    drops d / eye 
    VIFITEH, CJSC     Russia
  • Taurine
    solution
    DALHIMFARM, OJSC     Russia
  • Taurine
    drops d / eye 
    Armavir Biofactory, FKP     Russia
  • Taurine
    drops d / eye 
    Firm VIPS-MED, LLC     Russia
  • Taurine
    films d / eye 
    Progress RCC, JSC     Russia
  • Taurine
    drops d / eye 
    SLAVYANSKAYA APTEKA, LLC     Russia
  • Taurine
    drops d / eye 
    Company DEKO, LLC     Russia
  • Taurine
    drops d / eye 
    TATHIMFARMPREPARATY, JSC     Russia
  • Taurin-Akos
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Taurin-DIA
    drops d / eye 
    DIAPHARM Institute of Molecular Diagnostics, ZAO     Russia
  • Taurin-SOLOFARM
    drops d / eye 
    GROTEKS, LLC     Russia
  • Taufon
    drops d / eye 
    MOSCOW ENDOCRINE FACTORY, FSUE     Russia
    • Dosage form: & nbspeye drops
    Composition:

    1 ml of the preparation contains:

    Active substance: taurine - 40 mg.

    Excipient: water for injection - up to 1 ml.

    Description:Transparent colorless liquid.
    Pharmacotherapeutic group:Metabolic means.
    ATX: & nbsp

    S.01.X.A   Other drugs for the treatment of eye diseases

    C.01.E.B   Other drugs for the treatment of heart disease

    Pharmacodynamics:

    Taurine is a sulfur-containing amino acid that forms in the body during the conversion of cysteine.

    An anticancer agent, it has a metabolic effect. Stimulates the processes of repair and regeneration in diseases of a dystrophic nature and diseases accompanied by a sharp disruption of the metabolism of the eye tissues. It promotes the normalization of the functions of cell membranes, the activation of energy and metabolic processes, the preservation of the electrolyte composition of the cytoplasm due to accumulation TO+ and Ca2+ , improving the conditions for carrying out a nerve impulse.

    Pharmacokinetics:

    With topical application, systemic absorption is low.

    Indications:

    The drug is used as part of complex therapy. Dystrophy of the cornea; cataracts (senile, diabetic, traumatic, radiation); trauma of the cornea (as a simulator of reparative processes). Primary open-angle glaucoma (in combination with β-adrenoblockers (to improve the outflow of intraocular fluid)).

    Contraindications:Increased individual sensitivity, children's age (up to 18 years).
    Carefully:

    No data.

    Pregnancy and lactation:

    The purpose of the drug during pregnancy and breastfeeding is possible only if the intended benefit to the mother exceeds the potential risk to the fetus or child.

    Dosing and Administration:

    Locally. The drug is used in the form of instillations.

    When cataracts - 1-2 drops 2-4 times a day for 3 months. The course is repeated at a monthly interval.

    In injuries and dystrophic diseases, corneas are used in the same doses for 1 month.

    In open-angle glaucoma (in combination with butylamine hydroxypropoxyphenoxymethylmethyloxadiazole or timolol maleate) 1-2 drops twice a day for 15-20 minutes ds appointment of one of the local antihypertensive drugs, for 6 weeks, followed by cancellation for 2 weeks.

    Side effects:Allergic reactions are possible.

    If the side effects indicated in the manual are aggravated, or you notice any otherside effects not listed in the instructions, tell your doctor about it.

    Overdose:

    Data on overdose are absent.

    Interaction:

    In patients with glaucoma (open-ended), a significant increase in the antihypertensive effect of β-blockers (butylamine hydroxypropoxyphenoxymethyl methyl oxadiazole or gimolol maleate) in the case of combined use with taurine. Strengthening the effect is achieved by increasing the coefficient of ease of outflow and reducing the production of aqueous humor.

    Special instructions:

    If necessary, simultaneous use of other ophthalmic drugs (eye drops, etc.). the interval between the use of taurine and other drugs should be at least 10-15 minutes.

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the management of motor vehicles and occupations of potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:

    Eye drops 4%.

    By 0.4 or 1 ml in drop-droppers from low-density polyethylene or polypropylene. For 5 or 10 tubes of intravenous drips in a bag of laminated paper or without it.

    For 2 or 4 bags with 5 tubes or 1 or 2 bags with 10 droppers, or 10 or 20 drop-drip along with instructions for use in a pack of cardboard.

    Packaging:(10) - bags, paper, laminated, packings, cardboard
    Tube-dropper polypropylene (10) - packs cardboard
    Tube-dropper polypropylene (20) - packs cardboard
    (5) - bags, paper, laminated, packings, cardboard
    (10) - bags, paper, laminated, packings, cardboard
    Tube-dropper polyethylene (10) - packs cardboard
    Tube-dropper polyethylene (20) - packs cardboard
    (5) - bags, paper, laminated, packings, cardboard
    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.
    Shelf life:

    3 years.

    Do not use after the expiration date!

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-003135
    Date of registration:10.08.2015
    The owner of the registration certificate:GROTEKS, LLC GROTEKS, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.09.2015
    Illustrated instructions
      Instructions
      Up